The 2026–27 Federal Budget provides several positive signals for genomics and precision medicine in Australia, particularly across precision oncology, clinical trials, medicines access, digital health and innovation policy. For InGeNA members, the Budget reflects...

InGeNA has released its new Position Statement on Genomics for Prevention and Population Screening, outlining the organisation’s support for the responsible, coordinated, and system-wide integration of genomics into prevention and population health strategies in...

A new era of precision medicine is taking shape with remarkable speed, and few recent developments exemplify this better than the success of CRISPR-based and gene therapy interventions for rare neurogenetic diseases. In the past several weeks, a series of global...